病毒学：当前研究

Due to COVID-19 Infection Impact on Secondary Respiratory Distress Syndrome

Abstract

Tanu Singhal

SARS-CoV-2 infection and its clinical manifestation as Coronavirus Disease 2019 that is COVID-19 present an unmatched worldwide public health problem. The disease presents an exclusive pathophysiology and clinical sequence currently existing therapeutic approaches. COVID-19 patients progressing or presenting into frank Acute Respiratory Distress Syndrome (ARDS) with typical decreased pulmonary compliance, represents another clinical enigma to many clinicians, since routine therapeutic interventions for ARDS are still a subject of debate.